Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care Units
TTV: EVARUCI
From Translation to Validation: Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care Units
1 other identifier
observational
100
1 country
1
Brief Summary
International guidelines recommend the use of Pressure Injury risk assessment tools. According to these guidelines, a systematic approach to assessing risk for PI development is essential. Although several tools have been developed, no single clinical pathway is considered superior. Instead, a comprehensive evaluation of risk factors, combined with visual skin assessment, is recommended. The aim of this study was to evaluate the applicability of the EVARUCI Scale in a Turkish intensive care unit setting by performing cross-cultural adaptation and linguistic validation, and to examine its validity and reliability through psychometric testing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedFirst Submitted
Initial submission to the registry
May 2, 2026
CompletedFirst Posted
Study publicly available on registry
May 8, 2026
CompletedMay 8, 2026
May 1, 2026
3 months
May 2, 2026
May 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EVARUCI Pressure Ulcer Risk Assessment Scale in Intensive Care
The EVARUCI was developed specifically for intensive care unit patients based on studies of common risk factors for pressure injuries in Spain. González et al. (2004) found that the EVARUCI scale had a suitable reliability when tested. Subsequently, Roca et al. (2015) concluded that the interobserver concordance for the EVARUCI scale was very high. The EVARUCI scale assesses level of consciousness, hemodynamic and respiratory status, and the mobility status of the patient. Each of these parameters is scored from 0 to 4. A fifth category called "other" assesses risk factors such as temperature, skin status, blood pressure, prone position, and length of stay in the ICU. The total score ranges from 4 (minimum risk) to 23 (maximum risk).
3 days
Eligibility Criteria
Intensive care unit patient
You may qualify if:
- Patients who are 18 years or older
- without a pressure injury at the time of ICU admission
- expected to stay in the ICU for at least 72 hours who consent to participate in the study (or whose family members consent) included in the study.
You may not qualify if:
- Patients or their family members who did not consent to participate
- Patients who transferred to another hospital during their ICU stay, excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University
Istanbul, Turkey (Türkiye)
Related Publications (2)
Garcia-Fernandez FP, Pancorbo-Hidalgo PL, Agreda JJ. Predictive capacity of risk assessment scales and clinical judgment for pressure ulcers: a meta-analysis. J Wound Ostomy Continence Nurs. 2014 Jan-Feb;41(1):24-34. doi: 10.1097/01.WON.0000438014.90734.a2.
PMID: 24280770BACKGROUNDPicoito RJBR, Lapuente SMMPDC, Ramos ACP, Rabiais ICM, Deodato SJ, Nunes EMGT. Risk assessment instruments for pressure ulcer in adults in critical situation: a scoping review. Rev Lat Am Enfermagem. 2023 Oct 6;31:e3983. doi: 10.1590/1518-8345.6659.3983. eCollection 2023.
PMID: 37820213BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nurten Ozen
Istanbul University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 100 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 2, 2026
First Posted
May 8, 2026
Study Start
October 1, 2025
Primary Completion
January 1, 2026
Study Completion
February 1, 2026
Last Updated
May 8, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share